论文信息 - Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study - 字舞流文

Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

L. Peyrin-Biroulet | S. Danese | F. Erlandsson | Y. Bouhnik | W. Brandt | M. Lukáš | M. Hansen | S. Keshav | J. Dupas | M. Knutsson | J. Rudzinski | P. Uebel | D. Kleczkowski